November 1, 2024
Sterile compounders: Check your ingredients
FDA issued a reminder this week to only produce sterile drugs with suitable components.
October 30, 2024
Not holding back
We pull no punches in this article about Novo's latest shenanigans
October 30, 2024
Video appearance: APC talks the legal issues
APC CEO Scott Brunner was a guest on "On The Pen" — a YouTube channel dedicated to all things GLP-1.
October 25, 2024
Full of sound and fury, signifying nothing
Novo Nordisk tried to convince the FDA that semaglutide injections are difficult to compound. (Spoiler: They aren't.)
October 24, 2024
PharmExec features APC execs talking about the compounding process
From the manufacturing process to patient and provider challenges, this PharmExec video interview covers all things compounding.
October 24, 2024
APC calls out Novo in Reuters
Reuters used our comment that there's a difference between making molecules and compounding with them.
October 23, 2024
CBS quotes APC on resolving shortages
Taking a different angle, this article looked how the FDA decides when to resolve a shortage.
October 23, 2024
The Brits could have done better
UK-based pharmaphorum is covering the GLP-1 issue, but it played down our rather important point about the ease of compounding with the drugs.
October 17, 2024
FDA issues IV fluids emergency guidance
The FDA has published emergency guidance that empowers pharmacies to help address the nationwide IV solutions shortage.
October 15, 2024
FDA reconsiders on tirzepatide, big questions remain
After a court order, the FDA agreed to reconsider taking tirzepatide off the shortage list.
October 11, 2024
Tirzepatide fallout in The Hill
The Hill writes one of the first stories on the fallout from the FDA's tirzepatide decision.
October 11, 2024
Reporter briefing: Patient impacts of tirzepatide shortage resolution
APC's media briefing shared compounders' first-hand stories with more than 30 reporters from across the country.
October 11, 2024
Be sure your marketing follows these best practices
APC's new guide will help you stay on the right side of laws and regs.
October 11, 2024
A fake survey from a pharma-funded organization
What the Partnership for Safe Medicines released "Ain't a legitimate survey."
October 11, 2024
Lots of letters
On the compounding front, the FDA’s inbox is getting quite a workout lately.
October 11, 2024
Slick new dosing pen for compounders
Love Lifesciences’ UniPen injector pen is not only a Very Big Deal, it's available at a discount for APC PFM members.
October 10, 2024
Echoing our position
Specialty Pharmacy Continuum has a great piece on the importance of a longer "tail" for 503As.
October 10, 2024
Wired story isn’t perfect, but…
This time Wired missed the mark on pharmacy compounding, but it at least quoted Scott and focused on the important issues.
October 9, 2024
Wired focuses on GLP-1 patient fallout
Wired looks at how some patients are being hit hard by tirzepatide coming off shortage.
October 9, 2024
Quartz mentions APC
Not a big deal, but it shows we're getting media coverage across the spectrum.
October 9, 2024
San Diego news radio focuses on GLP-1 price
It could have chosen any angle, and it went with the high price of commercial versions. 👍🏻
October 9, 2024
CNN gets it spot on
The article, which of course quotes APC, focuses on the impact on patients of tirzepatide coming out of shortage.
October 7, 2024
Medscape focuses on compounders
Medscape is the latest news outlet to cover tirzepatide, and it focuses on APC's perspective.
October 4, 2024
Commenting on the tirzepatide announcement
Since the FDA announced that tirzepatide is (for now) out of shortage, APC's Scott Brunner has been all over the news offering our perspective.
October 2, 2024
Get yer law and patient safety CE here
We've made the most popular segment of our 15-hour legal course into a standalone 3-hour, on-demand CE program.
October 2, 2024
Vet compounders: How has GFI 256 changed things?
Simply put, we want to know if you’ve been affected by recent FDA guidance on veterinary compounding.
September 27, 2024
Talking about those legal threats
Baseless but time-consuming lawsuit threats make compounders shy.
September 27, 2024
APC does its best in a Hill article
The piece spends a lot of time considering misconceptions about compounded GLP-1s, but it least it included a little straight info from Scott.
September 27, 2024
Weighing in on Lilly’s tirzepatide vials
Scott tells Medscape that actually helping patients with vial-based tirzepatide is a welcome change for Lilly.
